Tumor Metabolome Targeting and Drug Development Softcover reprint of the original 1st ed. 2014 Edition

Tumor Metabolome Targeting and Drug Development Softcover reprint of the original 1st ed. 2014 Edition book cover

Tumor Metabolome Targeting and Drug Development Softcover reprint of the original 1st ed. 2014 Edition

Author(s): Steven Kanner

  • Publisher: Humana
  • Publication Date: September 17, 2016
  • Edition: Softcover reprint of the original 1st ed. 2014
  • Language: English
  • Print length: 206 pages
  • ISBN-10: 1493953435
  • ISBN-13: 9781493953431

Book Description

In this volume, the major metabolic alterations identified in cancer and tumor-associated cells are explored, including discussions of former and emerging approaches to drug development in targeting cancer cell metabolism.

The metabolic network in cells promotes the generation of both energy and biomass needed for them to grow, divide and differentiate. However, the metabolism of malignant cells generally varies from that of normal cells. These differences provide a platform for the discovery of new approaches to targeting potential vulnerabilities in cancer cells for therapeutic options Some of the significant changes that occur involve ATP production and consumption that modulates the ATP to ADP ratio, hypoxia and the effects of reactive oxygen species on glycolysis, regulation of mitochondrial respiration, induction and suppression of autophagy, and the Warburg effect and “reverse” Warburg effect–these topics and more are discussed in this volume.

Editorial Reviews

From the Back Cover

In this volume, the major metabolic alterations identified in cancer and tumor-associated cells are explored, including discussions of former and emerging approaches to drug development in targeting cancer cell metabolism.

The metabolic network in cells promotes the generation of both energy and biomass needed for them to grow, divide and differentiate. However, the metabolism of malignant cells generally varies from that of normal cells. These differences provide a platform for the discovery of new approaches to targeting potential vulnerabilities in cancer cells for therapeutic options Some of the significant changes that occur involve ATP production and consumption that modulates the ATP to ADP ratio, hypoxia and the effects of reactive oxygen species on glycolysis, regulation of mitochondrial respiration, induction and suppression of autophagy, and the Warburg effect and “reverse” Warburg effect–these topics and more are discussed in this volume.

About the Author

Dr. Steven B. Kanner is the Vice President of Discovery Biology at Astex Pharmaceuticals. He has been a pharmaceutical research leader with over 20 years of extensive experience in novel target identification and validation, assay development, both small molecule and antibody drug discovery, and expertise in oncology, immunology and inflammation. For more detail, please see the attached CV herewith.

View on Amazon

未经允许不得转载:Wow! eBook » Tumor Metabolome Targeting and Drug Development Softcover reprint of the original 1st ed. 2014 Edition